OPKO Health (OPK) Tops Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.72 --0%
Revenue Growth %: -9.9%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
IEP, XPRO, GEF, More
Revenue Growth %: -9.9%
Financial Fact:
Net loss attributable to common Shareholders: -14.98M
Today's EPS Names:
IEP, XPRO, GEF, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.01), $0.09 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $182.2 million versus the consensus estimate of $184.7 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Upgrades Aon Corp (AON) to Outperform, 'Best OG and Best Re-Rate Potential'
- California Resources (CRC) Tops Q3 EPS by 21c
- Philips (PHG) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
